Phylodynamic and phylogeographic reconstruction of porcine reproductive and respiratory syndrome virus (PRRSV) in Europe: Patterns and determinants.


Journal

Transboundary and emerging diseases
ISSN: 1865-1682
Titre abrégé: Transbound Emerg Dis
Pays: Germany
ID NLM: 101319538

Informations de publication

Date de publication:
Sep 2022
Historique:
revised: 08 03 2022
received: 04 02 2022
accepted: 06 04 2022
pubmed: 12 4 2022
medline: 30 9 2022
entrez: 11 4 2022
Statut: ppublish

Résumé

Porcine reproductive and respiratory syndrome (PRRS) is among the most devastating diseases affecting the pig industry. Despite vaccines having been available for decades, the remarkable genetic variability of this virus, leading to poor cross-protection, has limited their efficacy, and other measures must be adopted to effectively control the viral circulation. Some recent studies have investigated the factors involved in viral spreading and persistence, at least at the local level. However, despite the topic's relevance, no statistically grounded evidence is currently available evaluating the variables more involved in porcine reproductive and respiratory syndrome virus (PRRSV) epidemiological success at a broader scale, such as the European scale. In the present study, an extensive phylodynamic and phylogeographic analysis was performed on more than 1000 ORF5 sequences to investigate the history, dynamics and spreading patterns of PRRSV within European borders. Moreover, several potential predictors, representative of swine population features and trade, human population, economy and geographic characteristics, were evaluated through a specifically designed generalized linear model (GLM) to assess their weight on viral migration rate between countries over time. Although pig stock density, mean PRRSV strain genetic diversity, investments in agriculture (including a likely role of vaccination) and farmer education were involved to a certain extent, the major determinant was proven to be by far the live pig trade. Providing a robust depiction of PRRSV European molecular epidemiology patterns and determinants, the present study could contribute to a more rational allocation of limited resources based on an effective prioritization of control measures.

Identifiants

pubmed: 35403349
doi: 10.1111/tbed.14556
pmc: PMC9790212
doi:

Substances chimiques

Viral Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2175-e2184

Informations de copyright

© 2022 The Authors. Transboundary and Emerging Diseases published by Wiley-VCH GmbH.

Références

Virus Res. 2010 Dec;154(1-2):7-17
pubmed: 20837072
Sci Rep. 2018 May 17;8(1):7811
pubmed: 29773820
Vaccine. 2021 Jul 5;39(30):4184-4189
pubmed: 34127292
Mol Biol Evol. 2016 Aug;33(8):2167-9
pubmed: 27189542
PLoS Biol. 2018 Aug 13;16(8):e3000003
pubmed: 30102691
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555
Mol Biol Evol. 2012 Sep;29(9):2157-67
pubmed: 22403239
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Virus Evol. 2021 Jul 15;7(2):veab060
pubmed: 34532062
Vaccine. 2015 Aug 7;33(33):4069-80
pubmed: 26148878
Viruses. 2021 Dec 14;13(12):
pubmed: 34960778
Transbound Emerg Dis. 2022 Sep;69(5):e2175-e2184
pubmed: 35403349
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
Virol Sin. 2017 Aug;32(4):342-345
pubmed: 28795353
Rev Sci Tech. 2011 Apr;30(1):95-106
pubmed: 21809756
Sci Rep. 2020 Apr 29;10(1):7289
pubmed: 32350378
Vet J. 2008 Sep;177(3):345-51
pubmed: 17644436
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Prev Vet Med. 2014 Jun 1;114(3-4):247-58
pubmed: 24674019
Transbound Emerg Dis. 2012 Mar;59 Suppl 1:1-2
pubmed: 22252141
Transbound Emerg Dis. 2021 Mar;68(2):667-683
pubmed: 32657491
Vaccine. 2009 Jun 8;27(28):3704-18
pubmed: 19464553
Philos Trans R Soc Lond B Biol Sci. 2008 Dec 27;363(1512):3985-95
pubmed: 18852111
Virus Res. 2010 Dec;154(1-2):86-97
pubmed: 20692304
J Vet Sci. 2020 Mar;21(2):e38
pubmed: 32233141
Vet Microbiol. 2013 Jul 26;165(1-2):21-8
pubmed: 23528651
Vet Microbiol. 2013 Jul 26;165(1-2):13-20
pubmed: 23380460
Nat Rev Genet. 2008 Apr;9(4):267-76
pubmed: 18319742
Arch Virol. 2008;153(8):1479-88
pubmed: 18592131
Arch Virol. 2015 Jan;160(1):215-24
pubmed: 25355432
Mol Biol Evol. 2010 Aug;27(8):1877-85
pubmed: 20203288
Vaccine. 2020 Mar 23;38(14):3050-3061
pubmed: 32122719
Virus Res. 2010 Dec;154(1-2):18-30
pubmed: 20801173
Virus Res. 2010 Dec;154(1-2):185-92
pubmed: 20837071
Mol Biol Evol. 2019 Jul 31;:
pubmed: 31364710
PLoS Pathog. 2014 Feb 20;10(2):e1003932
pubmed: 24586153
J Gen Virol. 2006 Jul;87(Pt 7):1835-1841
pubmed: 16760385
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Nat Commun. 2015 Mar 27;6:6696
pubmed: 25813399
Vet Rec. 2012 Mar 3;170(9):225
pubmed: 22238201
Ann N Y Acad Sci. 2016 Oct;1382(1):73-83
pubmed: 27434370
Vaccines (Basel). 2021 Apr 09;9(4):
pubmed: 33918580
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Vaccine. 2008 Feb 20;26(8):1063-71
pubmed: 18237827
Vet Microbiol. 2015 Jan 30;175(1):7-16
pubmed: 25439650
Pathogens. 2020 Mar 17;9(3):
pubmed: 32192210
PLoS One. 2017 Apr 17;12(4):e0172638
pubmed: 28414720
Infect Genet Evol. 2015 Apr;31:149-57
pubmed: 25660037
Mol Biol Evol. 2022 Feb 3;39(2):
pubmed: 34951645
Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):11495-11500
pubmed: 30348781

Auteurs

Giovanni Franzo (G)

Department of Animal Medicine, Production and Health (MAPS), University of Padua, Legnaro PD, Italy.

Giulia Faustini (G)

Department of Animal Medicine, Production and Health (MAPS), University of Padua, Legnaro PD, Italy.

Matteo Legnardi (M)

Department of Animal Medicine, Production and Health (MAPS), University of Padua, Legnaro PD, Italy.

Mattia Cecchinato (M)

Department of Animal Medicine, Production and Health (MAPS), University of Padua, Legnaro PD, Italy.

Michele Drigo (M)

Department of Animal Medicine, Production and Health (MAPS), University of Padua, Legnaro PD, Italy.

Claudia Maria Tucciarone (CM)

Department of Animal Medicine, Production and Health (MAPS), University of Padua, Legnaro PD, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH